The aptamer ARC1779 potently and specifically inhibits the excessive von Willebrand factor (vWF) activity and vWF-mediated ex vivo platelet function of patients with thrombotic thrombocytopenic purpura (TTP)

被引：1
|
作者：
Jilma, Bernd [1 ]
Mayr, Florian B. [1 ]
Knoebl, Paul [1 ]
Spiel, Alexander O. [1 ]
Mertino, Patricia G. [2 ]
Schaub, Robert [2 ]
Gilbert, James C. [2 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Archemix Corp, Cambridge, MA USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.279.279
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
279
引用
收藏
页码：89A / 89A
页数：1
相关论文
共 19 条
  • [1] The aptamer ARC1779 blocks von Willebrand factor-dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo
    Mayr, Florian B.
    Knoebl, Paul
    Jilma, Bernd
    Siller-Matula, Jolanta M.
    Wagner, Patricia G.
    Schaub, Robert G.
    Gilbert, James C.
    Jilma-Stohlawetz, Petra
    TRANSFUSION, 2010, 50 (05) : 1079 - 1087
  • [2] The anti von willebrand factor aptamer ARC1779 increases platelet counts in a patient with familial thrombotic thrombocytopenic purpura (TTP)
    Firbas, C.
    Jilma, B.
    Gilbert, J. C.
    Schranz, S.
    Knoebl, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 204 - 204
  • [3] Safety, pharmacokinetics and pharmacodynamics of the anti von willebrand factor aptamer ARC1779 in patients with acute thrombotic thrombocytopenic purpura (TTP)
    Jilma, B.
    Jilma, P.
    Gilbert, J. C.
    Hutabarat, R.
    Siller, J.
    Spiel, A.
    Gorczyca, M.
    Knoebl, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 59 - 59
  • [4] PROOF OF CONCEPT FOR THE ANTI VON WILLEBRAND FACTOR APTAMER ARC1779 IN A PATIENT WITH FAMILIAL THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
    Hobl, E. -L
    Gorczyca, M.
    Jilma, B.
    Gilbert, J.
    Hutabarat, R.
    Knoebl, P.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 64 - 65
  • [5] Anti-von Willebrand factor aptamer ARC1779 for refractory thrombotic thrombocytopenic purpura
    Knoebl, Paul
    Jilma, Bernd
    Gilbert, James C.
    Hutabarat, Renta M.
    Wagner, Patricia G.
    Jilma-Stohlawetz, Petra
    TRANSFUSION, 2009, 49 (10) : 2181 - 2185
  • [6] Inhibition of von Willebrand factor by ARC1779 in patients with acute thrombotic thrombocytopenic purpura
    Jilina-Stohlawetz, Petra
    Gorczyca, Monika E.
    Jilma, Bernd
    Siller-Matula, Jolanta
    Gilbert, James C.
    Knoebl, Paul
    THROMBOSIS AND HAEMOSTASIS, 2011, 105 (03) : 545 - 552
  • [7] Thrombotic thrombocytopenic purpura (TTP) is associated with a deficiency in von Willebrand factor (vWF) metalloproteinase and an increase in vWF-platelet binding.
    Tsai, HM
    Lian, ECY
    Sarode, R
    Gruppo, RA
    Chow, TW
    Moake, JL
    BLOOD, 1998, 92 (10) : 36A - 36A
  • [8] Increased von Willebrand factor (vWf)-platelet binding and decreased vWf-metalloproteinase in ticlopidine-induced thrombotic thrombocytopenic purpura (TTP).
    Rice, L
    Tsai, HM
    Chow, TW
    Moake, JL
    BLOOD, 1998, 92 (10) : 706A - 707A
  • [9] The aptamer ARC1779 is a potent and specific inhibitor of von willebrand factor mediated ex vivo platelet function in acute myocardial infarction
    Spiel, Alexander O.
    Mayr, Florian B.
    Ladani, Nathalie
    Wagner, Patricia G.
    Schaub, Robert G.
    Gilbert, James C.
    Jilma, Bernd
    PLATELETS, 2009, 20 (05) : 334 - 340
  • [10] Targeting von Willebrand factor as a novel anti-platelet therapy; Application of ARC1779, an Anti-vWF aptamer, against thrombotic risk
    Bae, Ok-Nam
    ARCHIVES OF PHARMACAL RESEARCH, 2012, 35 (10) : 1693 - 1699
12